The number of people living with cancer continues to grow around the world. The World Health Organisation predicts next year there will be 4.5 million new cancer cases and 6.7 million by 2040 – and that’s just in China. Globally there are 15 million today.
“Cancer is affecting everybody – almost everyone knows someone who has had it,” Invitrocue’s (ASX:IVQ) vice president of operations Martin Bach told Stockhead.
But while many ASX small caps are developing drugs, Invitrocue’s specialty is helping doctors make better decisions regarding treatment options.
Read more here.